174 related articles for article (PubMed ID: 11863103)
1. Reply to the article "The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group", by D. J. Ruiter et al. (Ann Oncol 2001; 12: 9-11). American Joint Committee on Cancer.
Balch CM; Mihm MC
Ann Oncol; 2002 Jan; 13(1):175-6. PubMed ID: 11863103
[No Abstract] [Full Text] [Related]
2. The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group.
Ruiter DJ; Testori A; Eggermont AM; Punt CJ
Ann Oncol; 2001 Jan; 12(1):9-11. PubMed ID: 11249056
[No Abstract] [Full Text] [Related]
3. Staging and prognosis of cutaneous melanoma.
Dickson PV; Gershenwald JE
Surg Oncol Clin N Am; 2011 Jan; 20(1):1-17. PubMed ID: 21111956
[TBL] [Abstract][Full Text] [Related]
4. The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care.
Keung EZ; Gershenwald JE
Expert Rev Anticancer Ther; 2018 Aug; 18(8):775-784. PubMed ID: 29923435
[TBL] [Abstract][Full Text] [Related]
5. Microstaging in cutaneous melanoma.
Ruiter DJ; Spatz A; van den Oord JJ; Cook MG;
J Pathol; 2001 Dec; 195(5):525-9. PubMed ID: 11745686
[TBL] [Abstract][Full Text] [Related]
6. Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase.
Deichmann M; Kahle B; Moser K; Wacker J; Wüst K
Br J Cancer; 2004 Aug; 91(4):699-702. PubMed ID: 15280926
[TBL] [Abstract][Full Text] [Related]
7. Current melanoma staging.
Petro A; Schwartz J; Johnson T
Clin Dermatol; 2004; 22(3):223-7. PubMed ID: 15262308
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the eighth American Joint Committee on Cancer staging system for malignant melanoma of the skin.
Abdel-Rahman O
Future Oncol; 2018 Feb; 14(5):471-481. PubMed ID: 29322826
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for melanoma.
Wisco OJ; Sober AJ
Dermatol Clin; 2012 Jul; 30(3):469-85. PubMed ID: 22800552
[TBL] [Abstract][Full Text] [Related]
10. The New American Joint Committee on Cancer staging system for cutaneous melanoma: a critical analysis based on data of the German Central Malignant Melanoma Registry.
Garbe C; Ellwanger U; Tronnier M; Brocker EB; Orfanos CE
Cancer; 2002 Apr; 94(8):2305-7. PubMed ID: 12001131
[No Abstract] [Full Text] [Related]
11. A new American Joint Committee on Cancer staging system for cutaneous melanoma.
Balch CM; Buzaid AC; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Houghton A; Kirkwood JM; Mihm MF; Morton DL; Reintgen D; Ross MI; Sober A; Soong SJ; Thompson JA; Thompson JF; Gershenwald JE; McMasters KM
Cancer; 2000 Mar; 88(6):1484-91. PubMed ID: 10717634
[TBL] [Abstract][Full Text] [Related]
12. Reflecting on the 2001 American Joint Committee on Cancer Staging System for melanoma.
Retsas S; Mastrangelo MJ
Semin Oncol; 2007 Dec; 34(6):491-7. PubMed ID: 18083372
[TBL] [Abstract][Full Text] [Related]
13. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
14. The new melanoma staging system.
Balch CM; Sober AJ; Soong SJ; Gershenwald JE;
Semin Cutan Med Surg; 2003 Mar; 22(1):42-54. PubMed ID: 12773013
[TBL] [Abstract][Full Text] [Related]
15. New American Joint Commission on Cancer staging system for melanoma: prognostic impact and future directions.
Ross MI
Surg Oncol Clin N Am; 2006 Apr; 15(2):341-52. PubMed ID: 16632219
[TBL] [Abstract][Full Text] [Related]
16. Testing a new staging system for cutaneous melanoma proposed by the American Joint Committee on Cancer.
Merkel S; Meyer T; Papadopoulos T; Schuler G; Göhl J; Hohenberger W; Hermanek P
Eur J Cancer; 2002 Mar; 38(4):517-26. PubMed ID: 11872344
[TBL] [Abstract][Full Text] [Related]
17. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C
J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477
[TBL] [Abstract][Full Text] [Related]
18. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.
Buzaid AC; Ross MI; Balch CM; Soong S; McCarthy WH; Tinoco L; Mansfield P; Lee JE; Bedikian A; Eton O; Plager C; Papadopoulos N; Legha SS; Benjamin RS
J Clin Oncol; 1997 Mar; 15(3):1039-51. PubMed ID: 9060544
[TBL] [Abstract][Full Text] [Related]
19. Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification.
Ferris LK; Farberg AS; Middlebrook B; Johnson CE; Lassen N; Oelschlager KM; Maetzold DJ; Cook RW; Rigel DS; Gerami P
J Am Acad Dermatol; 2017 May; 76(5):818-825.e3. PubMed ID: 28110997
[TBL] [Abstract][Full Text] [Related]
20. Review of the 2001 AJCC staging system for cutaneous malignant melanoma.
Schuchter LM
Curr Oncol Rep; 2001 Jul; 3(4):332-7. PubMed ID: 11389818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
